Mycoverse delivers 2G biologicals, driving the transition from chemistry to biology in row crops.
We combine our 3 strong technology pillars to deliver superior performing actives at unprecedented speed and cost:
1) A unique fungal strain collection established over 40 years
2) An AI driven high-throughput omics discovery platform
3) State-of-the-art fungal production technology
Spinning out of the world-renowned Technical University of Denmark, DTU, and a founding team with 50+ years of combined expertise in metabolites, biologicals and agriculture.
Mycoverse aims to close our ongoing pre-seed investment round Q4 2024.
Company Details
- Employees
- 6
- Founded
- -
- Address
- Søltofts Plads Building 223, Lundtofte,capital Region Of Denmark 2800,denmark
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- in metabolites.
- HQ
- Lundtofte, Capital Region of Denmark
Mycoverse Questions
Mycoverse's LinkedIn profile is https://dk.linkedin.com/company/mycoverse
Mycoverse has
6 employees.
View email and phone details for 6
employees at Mycoverse.
Mycoverse's industry is
Biotechnology Research
Mycoverse's top competitors are
Phanofi,
Glioray,
Prenaital,
Naturpladen,
Analona Therapeutics,
Sulis Therapeutics,
Darerl Aps,
Troya Therapeutics,
Arcanabio,
Nordicblue Aps.
Mycoverse's categories are Biotechnology Research
Mycoverse's founding year is 2024
